Pages that link to "Q40472871"

The following pages link to An atypical tumor necrosis factor (TNF) receptor-associated factor-binding motif of B cell-activating factor belonging to the TNF family (BAFF) receptor mediates induction of the noncanonical NF-kappaB signaling pathway. (Q40472871):

Displaying 50 items.

• TRAF3 controls activation of the canonical and alternative NFkappaB by the lymphotoxin beta receptor (Q24300996) ‎ (← links)
• CD40 in coronary artery disease: a matter of macrophages? (Q26752784) ‎ (← links)
• Roles of tumor necrosis factor receptor associated factor 3 (TRAF3) and TRAF5 in immune cell functions (Q26853280) ‎ (← links)
• Non-Canonical NF-κB Signaling Initiated by BAFF Influences B Cell Biology at Multiple Junctures (Q27024640) ‎ (← links)
• OTUD7B controls non-canonical NF-κB activation through deubiquitination of TRAF3 (Q28513798) ‎ (← links)
• Participation of B-cell-activating factor receptors in the pathogenesis of immune thrombocytopenia (Q33429051) ‎ (← links)
• The TRAF3 adaptor protein drives proliferation of anaplastic large cell lymphoma cells by regulating multiple signaling pathways (Q33953115) ‎ (← links)
• The nuclear factor-kappaB-interleukin-6 signalling pathway mediating vascular inflammation. (Q34030580) ‎ (← links)
• A BAFF-R mutation associated with non-Hodgkin lymphoma alters TRAF recruitment and reveals new insights into BAFF-R signaling. (Q34340672) ‎ (← links)
• Nuclear factor-κB-inducing kinase (NIK) contains an amino-terminal inhibitor of apoptosis (IAP)-binding motif (IBM) that potentiates NIK degradation by cellular IAP1 (c-IAP1). (Q34431075) ‎ (← links)
• Constitutive BR3 receptor signaling in diffuse, large B-cell lymphomas stabilizes nuclear factor-κB–inducing kinase while activating both canonical and alternative nuclear factor-κB pathways (Q34568850) ‎ (← links)
• Autosomal-dominant B-cell deficiency with alopecia due to a mutation in NFKB2 that results in nonprocessable p100. (Q35062895) ‎ (← links)
• Noncanonical NF-kappaB regulates inducible costimulator (ICOS) ligand expression and T follicular helper cell development (Q35149531) ‎ (← links)
• Differential expression of the adaptor protein HSH2 controls the quantitative and qualitative nature of the humoral response. (Q35228256) ‎ (← links)
• TNF superfamily protein-protein interactions: feasibility of small- molecule modulation (Q35534271) ‎ (← links)
• Crucial role for TNF receptor-associated factor 2 (TRAF2) in regulating NFκB2 signaling that contributes to autoimmunity (Q35546725) ‎ (← links)
• BAFF promotes proliferation of human mesangial cells through interaction with BAFF-R (Q35608647) ‎ (← links)
• Innate and Adaptive Immunity in Calcific Aortic Valve Disease (Q35612638) ‎ (← links)
• Site-specific ubiquitination is required for relieving the transcription factor Miz1-mediated suppression on TNF-α-induced JNK activation and inflammation. (Q35657765) ‎ (← links)
• Targeting signaling factors for degradation, an emerging mechanism for TRAF functions (Q35759267) ‎ (← links)
• Chimeric Vaccine Stimulation of Human Dendritic Cell Indoleamine 2, 3-Dioxygenase Occurs via the Non-Canonical NF-κB Pathway (Q35924786) ‎ (← links)
• Tumor necrosis factor receptor-associated factor 3 is a critical regulator of B cell homeostasis in secondary lymphoid organs (Q36156167) ‎ (← links)
• Role of BAFF and APRIL in human B-cell chronic lymphocytic leukaemia. (Q36530420) ‎ (← links)
• SNP-SNP interaction analysis of NF-κB signaling pathway on breast cancer survival (Q36545934) ‎ (← links)
• Intracellular signals and events activated by cytokines of the tumor necrosis factor superfamily: From simple paradigms to complex mechanisms. (Q36597952) ‎ (← links)
• Antibody deficiency associated with an inherited autosomal dominant mutation in TWEAK. (Q36729652) ‎ (← links)
• Multiple roles of TRAF3 signaling in lymphocyte function. (Q36961021) ‎ (← links)
• B cell survival: an unexpected mechanism of lymphocyte vitality (Q37168165) ‎ (← links)
• BAFF-R promotes cell proliferation and survival through interaction with IKKbeta and NF-kappaB/c-Rel in the nucleus of normal and neoplastic B-lymphoid cells (Q37187531) ‎ (← links)
• TRAF2 and TRAF3 independently mediate Ig class switching driven by CD40. (Q37291416) ‎ (← links)
• NF-κB inducing kinase: A key regulator in the immune system and in cancer (Q37777775) ‎ (← links)
• Non-canonical NF-κB signaling pathway (Q37822660) ‎ (← links)
• Roles for TNF-receptor associated factor 3 (TRAF3) in lymphocyte functions (Q38179139) ‎ (← links)
• A CD40 Kozak sequence polymorphism and susceptibility to antibody-mediated autoimmune conditions: the role of CD40 tissue-specific expression. (Q38303947) ‎ (← links)
• Signaling mechanisms regulating B-lymphocyte activation and tolerance (Q38334794) ‎ (← links)
• Genetics of common variable immunodeficiency: role of transmembrane activator and calcium modulator and cyclophilin ligand interactor (Q38533817) ‎ (← links)
• Development of a Novel BAFF Responsive Cell Line Suitable for Detecting Bioactive BAFF and Neutralizing Antibodies against BAFF-Pathway Inhibiting Therapeutics (Q38673541) ‎ (← links)
• Impairment of Mature B Cell Maintenance upon Combined Deletion of the Alternative NF-κB Transcription Factors RELB and NF-κB2 in B Cells (Q38798777) ‎ (← links)
• B Cell-Activating Factor (BAFF)-Targeted B Cell Therapies in Inflammatory Bowel Diseases. (Q38961202) ‎ (← links)
• The non-canonical NF-κB pathway in immunity and inflammation (Q39350735) ‎ (← links)
• B-cell-activating factor and autoimmune myasthenia gravis (Q40179681) ‎ (← links)
• B-lymphocyte stimulator/a proliferation-inducing ligand heterotrimers are elevated in the sera of patients with autoimmune disease and are neutralized by atacicept and B-cell maturation antigen-immunoglobulin (Q41182083) ‎ (← links)
• Analysis of the regulatory role of BAFF in controlling the expression of CD21 and CD23. (Q41762909) ‎ (← links)
• Deubiquitinating enzyme CYLD regulates the peripheral development and naive phenotype maintenance of B cells (Q42510282) ‎ (← links)
• A role for BLyS in the activation of innate immune cells (Q42742005) ‎ (← links)
• LMP1 protein from the Epstein-Barr virus is a structural CD40 decoy in B lymphocytes for binding to TRAF3. (Q45436282) ‎ (← links)
• Kinase MEKK1 is required for CD40-dependent activation of the kinases Jnk and p38, germinal center formation, B cell proliferation and antibody production (Q46892881) ‎ (← links)
• NF-κB inducing kinase is a therapeutic target for systemic lupus erythematosus. (Q48250996) ‎ (← links)
• Microenvironmental stromal cells abrogate NF-κB inhibitor-induced apoptosis in chronic lymphocytic leukemia. (Q49196241) ‎ (← links)
• TRAF3 binds BAFFR:BAFF (Q50293046) ‎ (← links)